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Abstract
Background: Folic acid is recommended to reproductive-aged women to prevent birth defects, though little is known
about the effects of dietary intake on other reproductive outcomes. Improved pregnancy rates have been documented after
folic acid supplement use, suggesting a possible link with ovulation, however research is limited. Our objective was to
evaluate the association between dietary folate intake, hormone levels, and sporadic anovulation in healthy, regularly
menstruating women.
Methodology/Principal Findings: The BioCycle study (2005–2007) prospectively followed 259 healthy women aged 18–44
years from the western New York region for up to 2 menstrual cycles. Total folate and specific sources of folate were
assessed up to 4 times per cycle by 24-hour recall. Estradiol, progesterone, luteinizing hormone, and follicle-stimulating
hormone were measured in serum up to 8 times per cycle, timed using fertility monitors. Anovulation was defined as a cycle
with peak progesterone concentration #5 ng/mL and no LH peak in the mid/late luteal phase. Higher intake of dietary
folate (in dietary equivalents) across tertiles had a marginally significant association with greater luteal progesterone levels
(P trend 0.08). Higher intake of synthetic folate was significantly associated with higher luteal progesterone levels (P trend
0.05). Specifically, women in the 3
rd tertile of synthetic folate intake had, on average, 16.0% (95% CI, 0.5–33.8%) higher luteal
progesterone levels compared to women in the 1
st tertile. Moreover, consumption of synthetic folate was significantly and
inversely associated with anovulation such that women in the 3
rd tertile had a 64% (95% CI, 8–86%) decreased odds of
anovulation compared to the women in the 1
st tertile (P trend 0.03).
Conclusions/Significance: These findings suggest that a diet high in synthetic folate may be associated with increased
progesterone levels and lower risk of sporadic anovulation. Further study of the effect of dietary folate and folic acid
supplement use on reproductive health is warranted.
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Introduction
In the early 1990s, periconceptional folic acid supplement use
was found to reduce both the occurrence [1] and reoccurrence [2]
of neural tube defects. These discoveries led not only to the
recommendation of folic acid supplement use to reproductive-aged
women, but also to the fortification of foods with folic acid in
several countries [3,4,5,6]. Despite folic acid supplement use being
heralded as one of the most significant public health measures for
the prevention of neural tube defects, little is known about the
effects of dietary intake on pre-pregnancy reproductive outcomes.
Folate is necessary for the synthesis of DNA, transfer RNA, and
the amino acids cysteine and methionine. Thus, it plays an
important role in human reproduction [7]. In animals, folic acid
supplementation increased ovulation rates (and subsequently litter
sizes) in pigs [8] while folic acid deficiency decreased ovulation in
rats [9]. Previous human studies documented higher pregnancy
rates among users of micronutrient supplements either with [10]
or without [11] fertility disorders. Further, regular use of
multivitamins was associated with a decreased risk of ovulatory
infertility with B vitamins, in particular folic acid, explaining some
of this association [12]. However, human studies have yet to
PLOS ONE | www.plosone.org 1 September 2012 | Volume 7 | Issue 9 | e46276pinpoint a specific nutrient in multivitamins explaining the
beneficial effect.
The objective of this study was to evaluate the association
between dietary folate consumption and reproductive hormone
levels and risk of incident sporadic anovulation in the BioCycle
Study. Based on folate’s biological activities, we initially hypoth-
esized that a low intake of folate (and subsequent elevated
homocysteine accumulation) could lead to reduced cell division,
increased inflammatory cytokine production, altered nitric oxide
metabolism, increased oxidative stress, elevated apoptosis, and
disturbed methylation reactions which could subsequently affect
oocyte development [13]. Therefore, our hypothesis was that
higher consumption of dietary folate would be associated with
higher reproductive hormone concentrations (estrogen, progester-
one, luteinizing hormone, and follicle-stimulating hormone) and a
lower risk of incident anovulation.
Methods
The BioCycle Study is a prospective cohort study of menstrual
cycle function conducted between 2005–2007 among 259 healthy,
premenopausal women 18 to 44 years of age from western New
York, and followed for one (n=9) or two (n=250) menstrual
cycles. To be eligible for the study, women had to have a self-
reported cycle length between 21 and 35 days for the past 6
months. Exclusion criteria included a history of gynecological
problems, endometriosis, fibroids, or polycystic ovary syndrome,
current regular use of oral contraceptives, vitamin and mineral
supplements, or prescription medications; pregnancy or breast-
feeding in the past 6 months; diagnosis of chronic medical
conditions, including metabolic disorders and gastrointestinal
diseases associated with malabsorption; self-reported body mass
index (BMI) at screening less than 18 or greater than 35 kg/m
2;o r
current dietary restrictions for weight loss or medical reasons.
Details of the study have been published elsewhere [14]. The
University at Buffalo Health Sciences Institutional Review Board
(IRB) approved the study, and served as the IRB designated by the
National Institutes of Health for this study under a reliance
agreement. All participants provided written informed consent.
Fasting blood specimen collection was scheduled in the morning
at up to 8 clinic visits per cycle. Visits were timed using fertility
monitors (Clear Blue Easy Fertility Monitor; Inverness Medical,
Waltham, MA, USA) and occurred on approximately the 2nd day
of menstruation, mid and late follicular phase, two days around
expected ovulation, and early, mid, and late luteal phase [15].
Collection and handling protocols were designed to minimize
variability in pre-analytical factors and have been previously
described [16]. All samples were processed and frozen at 280uC
within 90 minutes of phlebotomy, later shipped on dry ice to
analytical laboratories as a complete cycle, and measured
simultaneously, within a single analytical run, to limit analytical
variability. 94% of participants completed $7 clinic visits per cycle
and 100% completed 5 visits per cycle, with fewer visits typically a
result of shorter cycles.
Dietary intake was assessed by 24-hour dietary recalls on the
same days as blood sample collection and was conducted up to 4
times per cycle (corresponding to menses, mid follicular phase,
ovulation, and mid luteal phase), for a total of 8 possible recalls
over 2 cycles. The 24-hour recalls were conducted by trained
research staff. Dietary data were analyzed using the Nutrition
Data System for Research software version 2005 developed by the
Nutrition Coordinating Center of the University of Minnesota,
Minneapolis, MN. This program computed the nutrients, food
components, and food sources from the 24-hour dietary recalls.
Intakes of total and specific types of folate per woman were
calculated as the sum of the contributions from all foods on the
basis of U.S. Department of Agriculture food composition data.
Dietary folate equivalents (DFE) (in mg/day) were calculated to
account for differences in absorption between natural folate and
synthetic folate using the formula: natural folate + (synthetic folate
x 1.7) [17]. The majority of cycles had 4 dietary recalls (87%) and
all cycles had at least 2 recalls.
Reproductive hormones were measured in fasting serum
samples collected at each cycle visit at the Kaleida Health Center
for Laboratory Medicine (Buffalo, NY). Estradiol concentrations
were measured by radioimmunoassay. Follicle-stimulating hor-
mone (FSH), luteinizing hormone (LH), and progesterone were
measured using solid-phase competitive chemiluminescent enzy-
matic immunoassays by Specialty Laboratories Inc (Valencia, CA)
on the DPC Immulite 2000 analyzer (Siemens Medical Solutions
Diagnostics, Deerfield, IL). Across the study period the total
coefficient of variation (CV) for these tests reported by the
laboratory were ,10% for estradiol, ,5% for LH and FSH, and
,14% for progesterone. Cycles with progesterone concentrations
#5 ng/mL and no observed serum LH peak during the mid or
late luteal phase were considered anovulatory cycles [18]. Based
on this algorithm, 42 of the 509 cycles (8.3%) in this study were
classified as anovulatory. To account for variability in cycle and
phase length and potential for mistimed sample collection, visits
from ovulatory cycles were realigned based on the date of the LH
surge as indicated by the monitors [19]. Anovulatory cycles, as
defined above, are included in the current analysis and were not
modified by the realignment algorithm.
At baseline, height (in meters) and weight (in kilograms) were
measured using standardized techniques and BMI (kg/m
2) was
calculated. Participants also completed questionnaires on physical
activity, lifestyle, and reproductive health history. High, moderate,
and low physical activity categories were created based on
standard International Physical Activity Questionnaire cut points
[20]. Women completed diaries on their daily alcohol intake.
Based on these responses, women who consumed more than 4
drinks in one setting during a given menstrual cycle were classified
as periodic high alcohol consumers. Cycle length was defined as
the number of days between menstrual bleeding. Day one of the
cycle was defined as menstruating by 4:00 pm on that day; the last
day of the cycle was the last day before the next onset of bleeding.
All covariates assessed had at least a 95% response rate.
Statistical Analysis
Repeated-measures analysis of variance was used to compare
intake of dietary folate and other dietary components across the
cycle to evaluate patterns of occasional versus habitual folate
consumption. As no significant differences were observed, the
average daily intake for dietary folate and other dietary variables
were calculated per cycle for this analysis. Descriptive statistics
were calculated for demographic characteristics and dietary
nutrients according to tertile of average dietary folate intake (in
dietary equivalents) per day. Generalized linear mixed models
were used to test for associations between demographic variables,
dietary nutrients and tertiles of dietary folate intake. All
comparisons take repeated measures and correlations between
cycles into account and p-values presented are two-sided and
a=0.05. Dietary nutrients except for total calories and % of
calories from carbohydrate, protein, and fat are adjusted for total
calorie intake. Alternative cutoffs were explored to assess sensitivity
of results to this categorization, including quartiles and quintiles of
folate intake and categories corresponding to the US dietary
reference value (400 mg/day of DFE). Dietary composition was
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synthetic, and food sources of folate). Due to the high number of
non-consumers of beans, bean folate intake was categorized as
non-consumers (0 mg/day), consumers below the median (0.1–
81.4 mg/day), and consumers above the median (.81.4 mg/day).
To assess the association between folate intake and reproductive
hormone levels, we estimated the effects applying linear mixed
models with inverse probability weights [21,22]. All linear mixed
models included random intercepts to account for the variability in
baseline hormone levels between women and for the correlation
between cycles of the same woman. Inverse probability weights
were used to control for confounding because other reproductive
hormones (e.g., LH, progesterone, and FSH) represent time-
varying confounders that also act as intermediates when investi-
gating the independent association between dietary folate and
estrogen. Weights were based on the probability of an individual
consuming the amount of folate they actually consumed,
conditional on their fixed (demographic and dietary characteris-
tics) and time-varying (current and past hormone levels) covariates.
Ordinary least-squares regression was employed to obtain the
predicted probabilities used in constructing the stabilized weights.
Reproductive hormone levels were log transformed for
normality and results are presented as percent change from the
reference category, (exp(b)21)6100. For models of estradiol, up to
8 measurements across the cycle were considered; however for
progesterone only up to 3 measurements in the luteal phase were
considered and for LH and FSH only up to 3 measurements
around ovulation were considered. Generalized linear mixed
models were used to model the association between average folate
intake and the odds of anovulation [23]. The median value of each
tertile of dietary folate intake was used as a continuous variable to
test for linear trends across tertiles.
The presence of confounding was evaluated using a hybrid
approach combining prior knowledge using directed acyclic
graphs (DAGs) and a statistical approach based on change in
point estimates [24]. A set of variables was determined by a review
of the prior literature and a detailed DAG was created that
identified the variables that should be included in the models.
Covariates were then included in the model if they changed the
exposure coefficient by more than 15% and were significant at the
P=0.10 level. Factors that were found to affect the point estimates
were energy intake (continuous), race (white, black, and other), age
(continuous), and dietary fiber (continuous).
Highly correlated variables such as iron and vitamins B1, B2,
B3, B6, and B12 were analyzed as collinear variables and
potential confounders by adding the nutrients to the fully
adjusted model separately and then in combination to see if it
affected the magnitude and/or significance of the effect estimate
for folate. In addition, alternate definitions of anovulation were
used to assess the sensitivity of this classification. Effect
modification by factors previously documented to affect serum
folate levels such as BMI, smoking status, vitamin B12 intake,
and alcohol intake (periodic high alcohol intake and average
intake per day) were tested using cross-product terms in the
final multivariate models (P value for significance, 0.10). Further
sensitivity analyses included, a stratified analysis of folate and
reproductive hormones in ovulatory and anovulatory cycles
separately and an analysis using continuous folate (as opposed to
categorical folate) as the main exposure. SAS version 9.2 (SAS
Institute, Cary, NC, USA) was used for all statistical analyses.
All statistical analyses took multiple cycles per woman into
account and all p-values presented are two-sided.
Results
Overall this cohort of women was young (mean age: 27.3 yrs,
standard deviation (SD) 8.2) and of normal weight (mean BMI:
24.1 kg/m
2, SD 3.9). The majority of these women were
physically active (90.8% moderate to high physical activity), had
never smoked (81.9%), and were nulliparous (73.6%) (Table 1).
There were no significant differences in demographics across
tertiles of dietary folate intake. When looking at diet composition,
women in the highest tertile of dietary folate intake had
significantly higher total calorie, dietary fiber, B vitamins,
selenium, magnesium, calcium, potassium, vitamin C, vitamin E,
and iron intake. Women with anovulatory cycles were more likely
to be of younger age and nulliparous (Table S1).
BioCycle participants had a mean dietary folate intake of
500.5 mg/day (range, 77.3–2334.1 mg/day) (Table 2). The mean
was slightly lower than that reported in a similar age group of
women in NHANES III, 718 mg/day, most likely due to the fact
that BioCycle women were enrolled based on reporting currently
not consuming multivitamins or supplements [25]. However, our
mean folate intake was relatively higher compared to most
European cohorts of reproductive age women, not reporting
supplement use, most likely due to the mandated fortification of
grains with folic acid in the US [26,27]. On average, the dietary
folate consumed by women in the BioCycle Study was 50.8%
synthetic (folic acid) and 49.2% natural. Specifically, 29.1% of
dietary folate came from fortified cereals, 41.1% from fortified
grain products, 18.1% from vegetables, and 11.7% from beans.
Intake of total folate (in mg/day DFE) was not significantly
associated with estradiol, LH, or FSH levels; however it was
marginally associated with luteal progesterone levels (P for trend
0.08) (Table 3). Women in the highest tertile of synthetic folate
intake had 16% (95% CI, 1–34%) higher luteal progesterone levels
compared to women in the lowest tertile of synthetic folate intake
(Table 3). When considering the source of synthetic folate, both
grain and cereal folate did not have significant associations with
progesterone. No type of dietary folate was significantly associated
with estradiol, LH, or FSH.
Although intake of total folate was not significantly associated
odds of anovulation, synthetic folate was significantly and inversely
associated with the odds of anovulation (Table 4). Women in the
2
nd and 3
rd tertile of intake had 22% (95% CI 245%–68%) and
64% (95% CI 8–965%) decreased odds of anovulation respective-
ly, compared to women in the 1
st tertile (P for trend 0.03). Intake
of folate from fortified grain products and cereals (which is
predominately synthetic folate) had similar associations for
anovulation across tertiles. Women in the second category of
bean folate (consumers of 0.1–81.4 mcg/day) had significantly
decreased odds of anovulation compared to non-consumers;
however there was no linear trend across tertiles.
We assessed the effect of misclassification of anovulation
through a sensitivity analysis by comparing the results of a
commonly used classification for anovulation (progesterone
#5 ng/mL) (n=65 cycles) with a more conservative classification
(progesterone #3 ng/mL, where long cycles with only one luteal
phase progesterone measurement were classified as ovulatory)
(n=22 cycles). While the confidence intervals for the results were
much wider and p-values were slightly higher when the most
conservative classification was used due to decreased power, the
direction and magnitude of the association of folate with
anovulation was consistent. For example, the odds of anovulation
in the third tertile of synthetic folate compared to the first tertile
was 58% (95% CI 15–79%) decreased using the more liberal
definition of anovulation (P for trend 0.02) and 73% (95% CI
Folate and Reproductive Function
PLOS ONE | www.plosone.org 3 September 2012 | Volume 7 | Issue 9 | e46276237–95%) decreased using the more conservative definition of
anovulation (P for trend 0.07).
There was no significant effect modification of the association
between all types of folate and reproductive hormones by BMI
Table 1. Demographic and Dietary Characteristics of BioCycle Women by Dietary Folate Intake.
Total Cohort Tertiles of Dietary Folate Equivalents (mg/day) p-value
1
Range of Intake (mg/day) (median) 77.3–2334.1 (445.9) 77.3–388.5 (325.0) 388.6–548.5 (444.9) 548.6–2334.1 (682.0)
n (number of cycles) 509 169 170 170
Demographics
2
Age, yrs 27.5 (8.2) 27.3 (8.2) 27.5 (8.5) 27.3 (8.0) 0.94
BMI, kg/m
2 24.1 (3.9) 24.3 (3.8) 24.3 (3.9) 23.6 (3.8) 0.16
Physical Activity, n (%) 0.46
Low 48 (9.5) 20 (11.9) 12 (7.1) 16 (9.5)
Moderate 182 (36.0) 58 (34.5) 68 (40.0) 56 (33.1)
High 275 (54.5) 90 (53.6) 90 (52.9) 97 (57.4)
Race, n (%) 0.55
Caucasian 300 (59.4) 91 (54.2) 101 (59.4) 109 (64.5)
African-American 100 (19.8) 46 (27.4) 27 (15.9) 27 (16.0)
Other 105 (20.8) 31 (18.5) 42 (24.7) 33 (19.5)
Years of Education, n (%) 0.33
# High School 65 (12.9) 25 (14.9) 21 (12.4) 18 (10.7)
Post-Secondary 440 (87.1) 143 (85.1) 149 (87.7) 151 (89.4)
Smoking Status, n (%) 0.72
Never or Former 487 (96.1) 160 (95.2) 164 (96.5) 163 (96.5)
Current 20 (3.9) 8 (4.8) 6 (3.5) 6 (3.6)
Nulliparous, n (%) 367 (73.6) 126 (77.3) 121 (72.9) 120 (70.6) 0.26
Age at Menarche, yrs 12.4 (1.2) 12.3 (1.3) 12.6 (1.3) 12.5 (1.1) 0.19
Cycle Length, days 28.8 (4.1) 28.8 (4.7) 28.9 (3.6) 28.8 (4.0) 0.87
Dietary Nutrients
2
Total Calories, kcal/day 1608.1 (405.0) 1383.4 (322.1) 1593.4 (316.7) 1846.2 (426.6) ,0.0001
Total Fat, % 33.9 (6.3) 35.6 (6.6) 33.6 (5.6) 32.4 (6.3) ,0.0001
Carbohydrate, % 50.9 (8.2) 48.7 (8.5) 51.1 (7.5) 52.8 (8.2) ,0.0001
Protein, % 15.7 (3.4) 16.1 (3.7) 15.8 (3.5) 15.4 (3.0) 0.07
Cholesterol, mg/dL 209.4 (115.7) 197.1 (100.6) 209.5 (106.2) 221.6 (136.4) 0.0002
Total Fiber, g/day 13.6 (6.0) 10.5 (4.7) 13.3 (4.7) 16.9 (6.5) ,0.0001
Folate Equivalents, mg/day 368.9 (148.2) 309.6 (62.1) 455.7 (43.3) 735.3 (207.2) ,0.0001
Thiamin (B1), mg/day 1.4 (0.5) 1.0 (0.2) 1.3 (0.2) 1.8 (0.5) ,0.0001
Riboflavin (B2), mg/day 1.7 (0.6) 1.3 (0.4) 1.6 (0.4) 2.1 (0.7) ,0.0001
Niacin (B3), mg/day 19.5 (6.7) 15.6 (4.5) 19.0 (5.2) 24.0 (7.2) ,0.0001
Vitamin B6, mg/day 1.5 (0.6) 1.1 (0.3) 1.4 (0.4) 1.9 (0.6) ,0.0001
Vitamin B12, mg/day 4.2 (6.4) 2.9 (3.6) 3.9 (6.2) 5.7 (8.2) 0.37
Selenium, mg/day 88.4 (27.9) 74.4 (23.6) 88.7 (23.5) 101.9 (29.3) 0.003
Magnesium, mg/day 222.1 (74.3) 182.2 (61.2) 216.0 (57.6) 267.9 (76.1) ,0.0001
Calcium, mg/day 697.9 (281.9) 548.5 (194.1) 687.8 (232.7) 856.7 (315.3) ,0.0001
Potassium, mg/day 1917.4 (607.0) 1609.4 (460.0) 1931.6 (559.1) 2209.4 (635.6) 0.006
Caffeine, mg/day 92.1 (98.9) 85.6 (86.8) 95.1 (105.6) 95.5 (103.5) 0.15
Vitamin C, mg/day 70.0 (43.1) 54.0 (37.0) 71.3 (39.0) 84.6 (47.0) 0.0002
Vitamin E, mg/day 9.8 (7.2) 7.1 (3.6) 8.5 (3.7) 13.8 (10.1) ,0.0001
Iron, mg/day 12.3 (5.1) 8.6 (2.1) 11.5 (2.8) 16.8 (5.5) ,0.0001
1Two-sided P-values were calculated using generalized linear mixed models. All comparisons take repeated measures and correlations between cycles into account.
Dietary nutrients except for total calories and % carbohydrate, protein, and fat from calories are adjusted for total calorie intake.
2Unless otherwise stated, values presented are mean (standard deviation).
3Parity totals do not add up to 509 cycles due to 10 missing responses.
doi:10.1371/journal.pone.0046276.t001
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2), smoking status (current vs. never or former),
average alcohol intake (,2.7 (median) vs. $2.7 g/day), periodic
high alcohol intake (,4 drinks vs. $4 drinks/day), or vitamin B12
intake (,3.1 (median) vs. $3.1 mg/day). The associations
between types of folate and reproductive hormone levels were
similar when restricting to ovulatory cycles and when using folate
as a continuous exposure (data not shown).
Discussion
We examined the relation of intakes of total folate and specific
sources of folate with reproductive hormones and anovulation in a
group of young, healthy women not using folate or other dietary
supplements at enrollment. We found that while total folate intake
(in dietary equivalents) was not significantly associated with
reproductive hormone levels or anovulation, higher intake of
dietary synthetic folate was significantly associated with higher
luteal progesterone levels and decreased odds of anovulation. The
observed association of high dietary synthetic folate intake with
increased progesterone levels and decreased risk of anovulation
highlights other potential beneficial effects of folic acid fortification
that to date may not have been recognized.
To our knowledge this is the first study to look at the association
between dietary folate and reproductive hormone levels and
anovulation in humans; however, there have been similar studies
looking at folic acid supplement use and ovulation in animals. In
immature superovulated rats, it was shown that either an excess or
deficiency of folates partially inhibited ovulation [9]. A later study
in rhesus monkeys showed that a folate-restricted diet led to
irregular menstrual cycles and progressively decreased pre-
ovulatory serum estradiol and mid-luteal progesterone compared
to monkeys fed a normal diet [28]. Finally, folic acid supplement
use in pigs was shown to promote ovulation as documented by
increased litter size [8].
Table 2. Intake of Folate by Type and Source in Women of
the BioCycle Study.
Types of Folate
(mg/day) Mean SD Min Median Max
% Total
Folate
Total Folate 368.9 148.2 69.2 336.4 1592.5 n/a
Folate Equivalents 500.5 217.8 77.3 445.9 2334.1 n/a
Synthetic Folate 187.5 111.6 10.1 158.1 1057.5 50.8
Cereal Folate 104.0 132.9 0.0 53.8 1120.3 29.1
Grain Folate 147.2 69.4 0.0 139.0 484.4 41.1
Natural Folate 181.7 82.2 49.2 166.2 954.3 49.2
Vegetable Folate 64.9 69.4 1.9 56.1 278.8 18.1
Bean Folate 42.0 87.3 0.0 0.0 716.8 11.7
doi:10.1371/journal.pone.0046276.t002
Table 3. Association between dietary folate intake and estradiol and progesterone in the BioCycle Study.
Estradiol Progesterone
Types of Folate (mg/day)
Tertile
(Median) % Change
1 95% CI
P for
trend % Change
1 95% CI P for trend
Folate Equivalents 1 (325.0) REF REF 0.97 REF REF 0.08
2 (444.9) 22.68 (212.98, 8.85) 6.38 (28.54, 23.73)
3 (682.0) 0.65 (28.43, 10.63) 16.03 (22.62 38.25)
Synthetic Folate 1 (100.9) REF REF 0.56 REF REF 0.05
2 (157.9) 26.09 (216.45, 5.55) 12.01 (24.03, 30.74)
3 (270.6) 2.33 (27.04, 12.64) 15.70 (0.05, 33.80)
Grain Folate 1 (83.2) REF REF 0.89 REF REF 0.33
2 (138.7) 4.79 (23.10, 13.31) 5.76 (25.79, 18.73)
3 (201.9) 3.04 (28.08, 15.51) 4.66 (27.00, 17.78)
Cereal Folate 1 (14.0) REF REF 0.58 REF REF 0.66
2 (53.7) 21.58 (211.05, 8.89) 1.69 (28.91, 13.51)
3 (192.4) 3.73 (22.78, 10.68) 1.71 (211.23, 16.53)
Natural Folate 1 (116.1) REF REF 0.24 REF REF 0.54
2 (166.1) 213.55 (224.37, 21.18) 7.08 (27.24, 23.61)
3 (242.0) 213.74 (229.37, 5.34) 14.21 (21.85, 32.88)
Vegetable Folate 1 (28.4) REF REF 0.89 REF REF 0.55
2 (56.0) 1.23 (24.40, 7.20) 6.58 (25.98, 20.82)
3 (101.5) 21.65 (27.13, 4.14) 5.87 (28.54, 22.55)
Bean Folate
2 1 (0.0) REF REF 0.55 REF REF 0.68
2 (48.8) 27.27 (3.07, 57.15) 9.37 (225.37, 60.27)
3 (160.4) 28.03 2(0.20, 64.25) 8.72 (220.89, 49.41)
Results for luteinizing hormone and follicle-stimulating hormone are not presented due to nonsignificant results.
1Results of weighted linear mixed models adjusted for age (continuous), race (White, Black, Other), BMI (continuous), mean total calorie (continuous), fiber intake
(continuous), and other reproductive hormones (log-transformed, continuous) by inverse probability weights. Results are expressed as % change, (exp(b)21)6100.
2Due to the low intake of bean folate, intake was categorized into non-consumers and consumers above and below the median intake of consumers (81.4 mcg/day).
doi:10.1371/journal.pone.0046276.t003
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min supplement use and fertility but for the most part have found
consistent results. In humans a significantly higher rate of
conceptions was found after preconceptional multivitamin supple-
ment use in comparison with a placebo-like trace element
supplement use in a Hungarian randomized, double-blind,
controlled trial (n=7,905) [11]. Similarly, in a double blind,
placebo-controlled study (n=93) looking at the effects of Fertility-
Blend (a type of multivitamin) for women on fertility, it was found
that after 3 months of supplement use, women on FertilityBlend
had a trend toward increased mean mid-luteal progesterone, had
significantly more days with luteal-phase basal temperatures over
98uF, and had a significantly higher rate of pregnancy than
women in the placebo group [29]. Finally, a longitudinal cohort
study (n=18,555) found an inverse association between frequency
of multivitamin use and ovulatory infertility [12]. While all of these
studies are consistent with our findings of folic acid being
beneficial for ovulation, none were able to pinpoint a nutrient
that was responsible for this association.
The observed relation between synthetic folate and anovulation
is biologically plausible. Specifically, folate deficiency and homo-
cysteine accumulation can lead to reduced cell division, increased
inflammatory cytokine production, altered nitric oxide metabo-
lism, increased oxidative stress, elevated apoptosis, and disturbed
methylation reactions [13]; all of which could subsequently affect
oocyte development. Studies of oocyte quality in the in vitro
fertilization setting have confirmed this showing that women
receiving a folic acid supplement (and who subsequently had lower
homocysteine follicular fluid concentrations) had better quality
oocytes and a higher degree of mature oocytes compared to
women who did not receive folic acid [30]. Although currently
research is limited, it is possible that ovarian response to
endogenous FSH pulses is also decreased in low folate conditions,
which could lead to impaired ovulation. In women undergoing
controlled hyperstimulation with recombinant FSH, carriers of the
T allele in position 677 of the MTHFR gene (which leads to
decreased enzyme activity and 5-methyltetrahydrofolate concen-
trations) have a decreased ovarian responsiveness to this hormone,
fewer oocytes to be retrieved [31], and granulosa cells that
produce less estradiol, basal and stimulated [32]. In regards to the
association between higher intake of dietary folate and higher
progesterone levels, while evidence in humans is limited, it has
been shown that folate deficiency in the rhesus monkeys leads to
depleted ovarian granulosa cells [28] and decreased levels of luteal
progesterone [33]. The authors of these articles hypothesized that
folate deficiency might led to an "ineffective" process or "abortive"
attempt at cell reproduction, the functional consequences of which
would be reflected in the reduced biosynthesis of the sex hormones
in these germ cells [28].
The reason for our significant finding with synthetic folate as
opposed to natural folate and anovulation could be partly due to
the greater absorption rates of synthetic folate [34]. While
calculating dietary folate equivalents attempted to address this
issue, it is known to be an imperfect measure [35]. Natural food
folate is present primarily in the reduced polyglutamated form
while synthetic folic acid is a fully oxidized monoglutamate form of
folate. Relative to folic acid, natural food folate has a lower
proportion of folate that is absorbed and available for metabolic
Table 4. Association between dietary folate in tertiles and sporadic anovulation in the BioCycle study.
Types of Folate (mg/day) Tertile (Median)
Adjusted
Odds Ratio
1 95% CI P for trend
Folate Equivalents 1 (325.0) REF REF 0.12
2 (444.9) 0.79 (0.34, 1.82)
3 (682.0) 0.49 (0.19, 1.23)
Synthetic Folate 1 (100.9) REF REF 0.03
2 (157.9) 0.68 (0.32, 1.45)
3 (270.6) 0.36 (0.14, 0.92)
Grain Folate 1 (83.2) REF REF 0.01
2 (138.7) 0.72 (0.32, 1.63)
3 (201.9) 0.33 (0.14, 0.81)
Cereal Folate 1 (14.0) REF REF 0.07
2 (53.7) 0.62 (0.30, 1.30)
3 (192.4) 0.44 (0.20, 0.96)
Natural Folate 1 (116.1) REF REF 0.44
2 (166.1) 1.46 (0.58, 3.70)
3 (242.0) 1.40 (0.48, 4.08)
Vegetable Folate 1 (28.4) REF REF 0.99
2 (56.0) 1.18 (0.50, 2.74)
3 (101.5) 1.03 (0.40, 2.64)
Bean Folate
2 1 (0.0) REF REF 0.68
2 (48.8) 0.11 (0.01, 0.85)
3 (160.4) 1.24 (0.44, 3.47)
1Generalized linear mixed models adjusted for age (continuous), race (White, Black, Other), BMI (continuous), and mean total calorie and fiber intake (both continuous).
2Due to the low intake of bean folate, intake was categorized into non-consumers and consumers above and below the median intake of consumers (81.4 mcg/day).
doi:10.1371/journal.pone.0046276.t004
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hinder the absorption of natural food folate including its limited
release from the food matrix, destruction within the gastrointes-
tinal tract, and incomplete hydrolysis of glutamates in excess of
one [34]. Since consumption of folic acid fortified foods (such as
ready to eat breakfast cereals) is associated with higher usual
vitamin B12 intakes this could also lead to a higher bioavailability
of synthetic folate [36]. Finally, it is possible that the presence of
other micronutrients added to fortified foods could explain some of
the association between synthetic folate and anovulation; however
models, which adjusted for highly correlated dietary nutrients
(such as vitamin B12) produced similar results.
The BioCycle Study had a number of strengths including the
intensive monitoring of a large number of young, ethnically
diverse women throughout 2 menstrual cycles, with multiple
measures of reproductive hormones and dietary intake. While self-
report of diet is subject to measurement error, the estimation of
dietary intake with multiple 24-hour recalls (up to 4 per cycle)
decreased the probability of dietary misclassification. Furthermore,
a Danish validation study showed that 3 24-hr recalls over 4 weeks
had a correlation of 0.49 with red blood cell folate (a biomarker of
long-term folate status) [26]. The prospective design and exclusion
criteria at baseline of the BioCycle Study strengthen the ability to
draw inference, having reduced the potential for bias from known
risk factors for anovulation. In addition, standardized assessment
of a wide variety of participant and dietary characteristics
increased the ability to adjust for confounding. Finally, since
BioCycle participants were not taking supplements, this allowed us
to examine the impact of low levels of folate intake from dietary
sources alone.
Nevertheless, the study faced several limitations, including the
small number of anovulatory cycles (n=42), which limited the
power of our findings. However, even with this moderate number
we observed a significant inverse association between synthetic
folate intakes and odds of anovulation. In addition, women were
only followed for 2 menstrual cycles. Since anovulation occurs
commonly in many women, long-term findings may be quite
different. In absence of a daily transvaginal ultrasound or daily first
morning urine measurements, the direct detection of ovulation has
some degree of misclassification. However, in a sensitivity analysis,
the effect of synthetic folate on anovulation was strong and
consistent regardless of the definition used for classification. While
our study included the use of a fertility monitor to help time visits,
bias could have been introduced through mistimed sample
collection. However, various indicators of successfully timed visits
were found to be unrelated to folate consumption, thus any
misclassification is likely to be non-differential [37]. As this was an
un-supplemented population, we were limited in evaluating the
association of dietary folate and reproductive function at modest
levels of consumption due to the small number of high consumers
(.1000 m/day). Given that this was an observational study, it is
possible that residual confounding by other lifestyle factors that
were poorly measured remains; however, adjustment for a variety
of demographic and dietary characteristics had little impact on the
results. Finally, since we restricted our study sample to healthy,
regularly menstruating women, we limited the generalizability of
our findings to other populations, specifically women who are
known to be chronically anovulatory.
In conclusion, we observed that higher intake of dietary
synthetic folate was significantly associated with higher luteal
progesterone levels and decreased odds of anovulation. These
results highlight the potential beneficial role of folic acid in
reproductive outcomes such as sporadic anovulation among
healthy women of reproductive age that to date might not have
been fully recognized. Future studies are needed to confirm these
findings as folic acid supplement use may have important
implications in improving fertility outcomes.
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